Reich N, Hlscher C (2024) Cholecystokinin (CCK): a neuromodulator with therapeutic potential in Alzheimers and Parkinsons disease
Originally isolated in 1973, GHK-Cu has become one of the most extensively studied peptides in regenerative medicine, with natural plasma levels declining from 200 ng/ml at age 20 to 80 ng/ml by age 60
Everyone was friendly from the first person I encountered to the very last
affordable yet effective options abound, but investing in trusted ones yields better results
Side-by-Side Research Applications GHK-Cu 50mg is better for: Copper peptide mechanism studies Gene expression research focused on GHK-Cu's known pathways Budget-limited single-compound protocols Research replicating existing GHK-Cu literature Studies where only one mechanism is being examined GLOW Blend is better for: Multi-pathway skin regeneration research Combined tissue repair and anti-aging protocols Simplified logistics for three-compound research Research where complementary mechanisms are the focus Studies comparing single-compound vs multi-compound approaches Which Researchers Choose Which In our experience at Durham Peptides, researchers new to the anti-aging peptide space often start with GHK-Cu alone to understand the compound's effects before adding complexity
Avoid unregulated or dubious sources, as they may not contain the stated amounts of glutathione or could pose health risks